Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher A Barker

Showing results (21-30 of 129) with videos related to

Pageof 13
Sort By:
Nuclear Medicine Communications|May 17, 2019
Clinical value of 18F-FDG-PET/CT in staging cutaneous squamous cell carcinomaSonia Mahajan, Christopher A Barker, Bhuvanesh Singh, et al.
Radiology and Oncology|December 2, 2014
Survival of patients treated with radiation therapy for anaplastic astrocytomaChristopher A Barker, Maria Chang, Kathryn Beal, et al.
Radiation Oncology Journal|June 17, 2016
Dosimetric comparison of axilla and groin radiotherapy techniques for high-risk and locally advanced skin cancerMalcolm D Mattes, Ying Zhou, Sean L Berry, et al.
Journal of Neuro-Oncology|May 6, 2014
EMPACT syndrome: limited evidence despite a high-risk cohortAndrew J Bishop, Maria Chang, Mario E Lacouture, et al.
Journal of the American Academy of Dermatology|November 2, 2020
Incidence of dermatologic adverse events in patients with cancer treated with concurrent immune checkpoint inhibitors and radiation therapy: A systematic review and meta-analysisBernice Y Yan, Gloria Wasilewski, Mario E Lacouture, et al.
JAAD Case Reports|June 6, 2017
Metastatic cutaneous apocrine carcinoma: Multidisciplinary approach achieving complete response with adjuvant chemoradiationBrian P Hibler, Christopher A Barker, Travis J Hollmann, et al.
Journal of Skin Cancer|August 20, 2014
Locally advanced and unresectable cutaneous squamous cell carcinoma: outcomes of concurrent cetuximab and radiotherapyRobert M Samstein, Alan L Ho, Nancy Y Lee, et al.
Journal of the American Academy of Dermatology|September 29, 2019
Restaging [<sup>18</sup>F] fludeoxyglucose positron emission tomography/computed tomography scan in recurrent cutaneous squamous cell carcinoma: Diagnostic performance and prognostic significanceSonia Mahajan, Christopher A Barker, Audrey Mauguen, et al.
American Journal of Clinical Oncology|January 29, 2025
Treatment of Cutaneous Adnexal Carcinoma With Radiotherapy: A 20-Year, Single-Institution Experience in 49 PatientsNader Mohamed, Sarah Mattessich, Daphna Y Gelblum, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2013
Valproic acid use during radiation therapy for glioblastoma associated with improved survivalChristopher A Barker, Andrew J Bishop, Maria Chang, et al.
Pageof 13

Showing results (21-30 of 129) with videos related to

Sort By:
Pageof 13
Nuclear Medicine Communications|May 17, 2019
Clinical value of 18F-FDG-PET/CT in staging cutaneous squamous cell carcinomaSonia Mahajan, Christopher A Barker, Bhuvanesh Singh, et al.
Radiology and Oncology|December 2, 2014
Survival of patients treated with radiation therapy for anaplastic astrocytomaChristopher A Barker, Maria Chang, Kathryn Beal, et al.
Radiation Oncology Journal|June 17, 2016
Dosimetric comparison of axilla and groin radiotherapy techniques for high-risk and locally advanced skin cancerMalcolm D Mattes, Ying Zhou, Sean L Berry, et al.
Journal of Neuro-Oncology|May 6, 2014
EMPACT syndrome: limited evidence despite a high-risk cohortAndrew J Bishop, Maria Chang, Mario E Lacouture, et al.
Journal of the American Academy of Dermatology|November 2, 2020
Incidence of dermatologic adverse events in patients with cancer treated with concurrent immune checkpoint inhibitors and radiation therapy: A systematic review and meta-analysisBernice Y Yan, Gloria Wasilewski, Mario E Lacouture, et al.
JAAD Case Reports|June 6, 2017
Metastatic cutaneous apocrine carcinoma: Multidisciplinary approach achieving complete response with adjuvant chemoradiationBrian P Hibler, Christopher A Barker, Travis J Hollmann, et al.
Journal of Skin Cancer|August 20, 2014
Locally advanced and unresectable cutaneous squamous cell carcinoma: outcomes of concurrent cetuximab and radiotherapyRobert M Samstein, Alan L Ho, Nancy Y Lee, et al.
Journal of the American Academy of Dermatology|September 29, 2019
Restaging [<sup>18</sup>F] fludeoxyglucose positron emission tomography/computed tomography scan in recurrent cutaneous squamous cell carcinoma: Diagnostic performance and prognostic significanceSonia Mahajan, Christopher A Barker, Audrey Mauguen, et al.
American Journal of Clinical Oncology|January 29, 2025
Treatment of Cutaneous Adnexal Carcinoma With Radiotherapy: A 20-Year, Single-Institution Experience in 49 PatientsNader Mohamed, Sarah Mattessich, Daphna Y Gelblum, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2013
Valproic acid use during radiation therapy for glioblastoma associated with improved survivalChristopher A Barker, Andrew J Bishop, Maria Chang, et al.
Pageof 13